title: [Analysis of gene expression profiles among 3 epithelial ovarian tumor subtypes using cDNA and tissue microarrays].
abstract: OBJECTIVE
  Ovarian cancer is the leading cause of death among the gynecological malignancy mainly due to lacking of effective early diagnostic methods. To identify novel candidate genes and further explore their clinical significance of epithelial ovarian tumors, we developed a new method in our laboratory by combining cDNA microarray with RNA in situ hybridization in frozen tissue microarray.
  
  
  METHODS
  cDNA microarrays were used to seek differentially expressed genes among 3 subtypes of ovarian tumors (serous borderline ovarian tumors, serous ovarian cancers, and endometrioid ovarian carcinomas). RNA in situ hybridization in frozen tissue microarray was used to further confirm the findings from cDNA microarrays.
  
  
  RESULTS
  In the study of cDNA microarray, 40 genes and ESTs showed significant differential expression between low and high-malignancy, as well as serous and endometrioid carcinomas. EPHB6, PTPRF, GFER, ERG25, PLRP1, FLJ22060, and WISP2 were further validated by RNA in situ hybridization in tissue microarray.
  
  
  CONCLUSIONS
  cDNA microarray combined with RNA in situ hybridization in frozen tissue microarray is an ideal choice for identifying novel oncogenes. EPHB6, PTPRF, GFER, ERG25, PLRP1, FLJ22060, and WISP2 might become the new candidate oncogenes for epithelial ovarian cancer.
authors.affiliation: Department of Gynecology, Cancer Center, Sun Yat-sen University, Guangzhou, Guangdong, 510060, P.R.China. zheng_min_1999@yahoo.de
authors.forename: Min
authors.initials: M
authors.lastname: Zheng
authors.forename: R
authors.initials: R
authors.lastname: Simon
authors.forename: J
authors.initials: J
authors.lastname: Kononen
authors.forename: G
authors.initials: G
authors.lastname: Sauter
authors.forename: M J
authors.initials: MJ
authors.lastname: Mihatsch
authors.forename: H
authors.initials: H
authors.lastname: Moch
mesh_terms: D055511:CCN Intercellular Signaling Proteins; D018269:Carcinoma, Endometrioid / Q000235:genetics / Q000378:metabolism; D018284:Cystadenocarcinoma, Serous / Q000235:genetics / Q000378:metabolism; D005260:Female; D020869:Gene Expression Profiling; D006801:Humans; D017403:In Situ Hybridization; D036341:Intercellular Signaling Peptides and Proteins / Q000378:metabolism; D008049:Lipase / Q000378:metabolism; D009363:Neoplasm Proteins / Q000378:metabolism; D020411:Oligonucleotide Array Sequence Analysis; D009857:Oncogenes; D010051:Ovarian Neoplasms / Q000235:genetics* / Q000378:metabolism; D036261:Receptor, EphB6 / Q000378:metabolism; D012097:Repressor Proteins; D014157:Transcription Factors / Q000378:metabolism
chemical_list: D055511:CCN Intercellular Signaling Proteins; C413323:CCN5 protein, human; D036341:Intercellular Signaling Peptides and Proteins; D009363:Neoplasm Proteins; D036261:Receptor, EphB6; D012097:Repressor Proteins; D014157:Transcription Factors; D008049:Lipase; C075987:pancreatic lipase-related protein 1